News

Allergan Inc. and Molecular Partners AG have entered into two agreements to discover, develop, and commercialize proprietary therapeutic designed ankyrin repeat protein (DARPin) products for the treatment of opthalmic diseases.

Gevokizumab, an IL-1 beta-modulating antibody from XOMA Corp., has received FDA orphan drug designation for the treatment of several types of non-infectious uveitis.

Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a $1 million donation made to the American Academy of Ophthalmology.

Educating the public about cataract risk factors, detection, and treatment options has been the goal of the American Academy of Ophthalmology (AAO) EyeSmart program during August, Cataract Awareness Month.

The Foundation Fighting Blindness is funding projects related to age-related macular degeneration, retinitis pigmentosa, Leber's congenital amaurosis, and Usher syndrome.

Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).

A study found that accommodative changes in the central anterior chamber depth (ACD) of patients with high myopia were less pronounced than emmetropic eyes.

A short video of capsulotomy creation with the VICTUS femtosecond laser.

Allergan and Molecular Partners AG have expanding their relationship with two new agreements for DARPin products.

Insight Software, creators of My Vision Express, has been ranked by Inc. magazine as one of the nation's fastest-growing private companies.

Patient enrollment has begun in a phase III clinical trial of a low dose of bromfenac for pain and inflammation reduction after cataract surgery.

Prevent Blindness America (PBA) has designated September as Sports Eye Safety Awareness Month.

Compared to an average of all physicians, ophthalmologists fared slightly better in a survey of physician burnout.

The 256+ channel Boston subretinal prosthesis is on track for in vivo validation of function and an FDA investigational device exemption application.

Check out this video demonstration of Swing Box, indoor golf net invented by Joe Lee, MD, ophthalmologist.

In a study from Emory University in Atlanta, ophthalmologists rated the same images higher on iPhone screens than desktop computer screens.

Corcoran Compliance Connection will provide real-time coding recommendations based on chart documentation in electronic health record (EHR) systems.

Prevent Blindness America (PBA) has declared August as Children's Eye Health and Safety Month to educate parents on the importance of children's healthy vision.

VSP Vision Care estimates it has spent about $150 million to provide free eye care and eyewear to 775,000 low-income, uninsured people in the past 15 years.

Alex V. Levin, MD, chief of pediatric ophthalmology and ocular genetics at Wills Eye Institute, has received a grant from Prevent Blindness America.

Bascom Palmer Eye Institute at the University of Miami is the top ophthalmology hospital for the ninth year in a row, according to U.S. News & World Report.

Phototherapeutic keratectomy (PTK) provides excellent visual outcomes in patients with irregular astigmatism and corneal opacity.

The FDA has approved once-monthly, 0.3-mg ranibizumab injection (Lucentis, Genentech) for treatment of diabetic macular edema (DME), making it the first and only drug approved by the agency for the condition. The standard of care for DME for the past 25 years has been laser surgery.

Lucentis, the 0.3-mg dose of ranibizumab injection, has been approved by the FDA for treatment of diabetic macular edema (DME).

A study, published in the Journal of Pediatric Ophthalmology and Strabismus, found exophoria to be a risk factor in 3D asthenopia (symptoms related to 3D viewing).

Bausch + Lomb (B + L) and Technolas Perfect Vision GmbH (TPV) have received 510(k) clearance from the FDA for femtosecond laser platform, Victus.

Sightpath, a provider of mobile and fixed ophthalmic surgical products, ramped up social media efforts with Facebook, Twitter, Vimeo, LinkedIn, and a blog.

Ernest Cavin, MBA, DBA, has been named president and chief executive officer of Haag-Streit USA and Reliance Medical Products, both based in Mason, OH.